# Nerivio Long-term Usage in Patients With Migraine

> **NCT06738056** · — · COMPLETED · sponsor: **Theranica** · enrollment: 244 (actual)

## Conditions studied

- Migraine
- Acute Treatment of Migraine

## Interventions

- **DEVICE:** Nerivio

## Key facts

- **NCT ID:** NCT06738056
- **Lead sponsor:** Theranica
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-01
- **Primary completion:** 2024-12-20
- **Final completion:** 2024-12-22
- **Target enrollment:** 244 (ACTUAL)
- **Last updated:** 2025-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06738056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06738056, "Nerivio Long-term Usage in Patients With Migraine". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06738056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*